Suven Life Sciences

quarterly
yearly
ParticularsMar '24Jun '24Sep '24Dec '24Mar '25
Revenue6.674.946.603.182.66
Expenses10.7912.6017.6816.4517.73
EBITDA-2.59-6.15-9.60-11.73-13.72
EBIT-4.10-7.65-11.05-13.26-15.07
Profit Before Tax-4.12-7.67-11.07-13.27-15.07
Net Profit-3.12-7.67-11.07-13.27-15.07
Financial Ratios
Operating Profit Margin-108.37%-609.90%-373.54%-728.57%-933.33%
Net Profit Margin-130.54%-759.41%-430.74%-824.22%-1,025%
Earning Per Share (Diluted)-0.14-0.35-0.51-0.61-0.69
Dividends Per Share0.000.000.000.000.00